IFNA1 and systemic lupus erythematosus: To use genomic tools to study the mechanisms of SLE, we and others have independently identified a gene expression signature for lupus patients using microarray profiling [12]–[14], which highlights the pathogenic role of the abnormal activation of the type I interferon (IFN) pathway in human lupus [15]–[17].